Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase I/IIa Study Using T-cell Receptor Gene Therapy in Metastatic Melanoma

NCT02654821 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT02654821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase I/IIa Study Using T-cell Receptor Gene Therapy in Metastatic Melanoma
Lead sponsor
The Netherlands Cancer Institute
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
January 31, 2020
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eye; melanoma, stage iv skin melanoma